iShares Biotechnology ETF (IBB)
NASDAQ: IBB · Real-Time Price · USD
195.70
+5.58 (2.93%)
At close: Jul 2, 2026, 4:00 PM EDT
195.20
-0.50 (-0.26%)
After-hours: Jul 2, 2026, 7:57 PM EDT
IBB Holdings Information
IBB is an equity ETF with a total of 253 individual holdings. The top holdings are Vertex Pharmaceuticals stock at 8.10%, Amgen at 7.81%, Gilead Sciences at 6.82%, Regeneron Pharmaceuticals at 4.92%, and argenx SE at 3.68%.
Total Holdings
253
Top 10 Percentage
44.74%
Asset Class
Equity
ETF Category
Health
Assets
7.84B
PE Ratio
22.88
Breakdown by Country
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 8.10% |
| 2 | AMGN | Amgen Inc. | 7.81% |
| 3 | GILD | Gilead Sciences, Inc. | 6.82% |
| 4 | REGN | Regeneron Pharmaceuticals, Inc. | 4.92% |
| 5 | ARGX | argenx SE | 3.68% |
| 6 | ALNY | Alnylam Pharmaceuticals, Inc. | 3.13% |
| 7 | NTRA | Natera, Inc. | 2.94% |
| 8 | RVMD | Revolution Medicines, Inc. | 2.78% |
| 9 | BIIB | Biogen Inc. | 2.39% |
| 10 | ILMN | Illumina, Inc. | 2.16% |
| 11 | MRNA | Moderna, Inc. | 2.05% |
| 12 | ONC | BeOne Medicines AG | 1.81% |
| 13 | INSM | Insmed Incorporated | 1.79% |
| 14 | INCY | Incyte Corporation | 1.76% |
| 15 | UTHR | United Therapeutics Corporation | 1.75% |
| 16 | ROIV | Roivant Sciences Ltd. | 1.41% |
| 17 | NBIX | Neurocrine Biosciences, Inc. | 1.29% |
| 18 | ASND | Ascendis Pharma A/S | 1.29% |
| 19 | GMAB | Genmab A/S | 1.13% |
| 20 | EXEL | Exelixis, Inc. | 1.03% |
| 21 | IONS | Ionis Pharmaceuticals, Inc. | 1.00% |
| 22 | BBIO | BridgeBio Pharma, Inc. | 0.98% |
| 23 | MEDP | Medpace Holdings, Inc. | 0.98% |
| 24 | MDGL | Madrigal Pharmaceuticals, Inc. | 0.87% |
| 25 | TECH | Bio-Techne Corporation | 0.86% |
As of Jul 1, 2026